1. Oates M, McGhan WF, Corey R. Pharmacoeconomics of cardiovascular medicine. In: Contemporary cardiology: preventative cardiology: insights into the prevention and treatment of cardiovascular disease. 2nd ed. New York: Humana Press; 2006. p. 309–24.
2. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney Books; 1996.
3. Bungay KM, Sanchez LA. Types of economic and humanistic outcomes assessments. In: Bressler LR, DeYoung GR, El-Ibiary S, et al., editors. The pharmacotherapy preparatory course: 2010 updates in therapeutics, vol. 2. Lenexa: American College of Clinical Pharmacy; 2010. p. 363–99.
4. Roger VL, Go AS, Lloyd-Jones DM, Writing Group Members. Heart disease and stroke statistics–2012 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2012;125:e12–230.
5. Webb GD, Smallhorn JF, Therrien J, Redington AN. Chapter 65. Congenital heart disease. In: Bonow RO, Man DL, Zipes DP, Libby P, editors. Braunwald’s Heart disease: a textbook of cardiovascular medicine. 9th ed. Philadelphia: Saunders Elsevier; 2011.